網球名將莎拉波娃進入哈佛商學院深造

She might be serving a two-year doping ban, but tennis star Maria Sharapova won't be twiddling her thumbs during that enforced sabbatical after enrolling for a course at the prestigious Harvard Business School.

網球名將瑪利亞·莎拉波娃雖然面臨長達兩年的興奮劑禁令，但已經在著名的哈佛商學院註冊的她，也不會在這樣的強制休假中游手好閒。

The tennis superstar posted a photo of herself at the campus gates on Twitter and Facebook last weekend.

上週末，這位網球巨星在推特和臉書上發佈了一張她在校園大門前的照片。

The Harvard Business School's admissions process is notoriously tough, accepting only 11% of all 2016 applicants. Sharapova's representatives did not immediately respond to CNN's request to clarify what qualifications, if any, she will gain.

哈佛商學院的招生十分嚴格，2016名申請者中只有11%被接受。莎拉波娃的經紀公司沒有立即回覆CNN關於她將獲得什麼證書（如果有的話）的詢問。

Sharapova tested positive for meldonium during January's Australian Open, a medication added to the list of banned substances at the start of 2016.

莎拉波娃在一月份的澳大利亞網球公開賽的藥物檢查中美度銨顯示陽性，這是2016年才劃入禁用行列中的一種藥。

Porsche and TAG Heuer dropped their endorsements of Sharapova, while the United Nations also suspended the athlete's status as a goodwill ambassador with its Development Program; a job described by Sharapova as "one of my proudest contracts ever."

隨後，保時捷和豪雅取消了莎拉波娃的代言，聯合國也取消了她作爲運動員在發展計劃中的親善大使身份；莎拉波娃曾把這項工作描述爲“我最引以爲傲的合同。”

Her ban lasts until January 25, 2018, though Sharapova has launched an appeal to the Court of Arbitration for Sport (CAS). Sharapova says had she taken the heart medication since 2006, and was unaware it had been added to the World Anti-Doping Agency (WADA) banned list.

她的禁令將一直持續到2018年1月25號，目前莎拉波娃已經向體育仲裁法院發起上訴。莎拉波娃表示，她從2006年起使用這種心臟藥物，並不知曉它已被劃入世界反興奮劑機構的禁用名單。

The CAS is expected to deliver its ruling by July 18. But even if the ban is upheld, Sharapova appears already prepared for a life after tennis.

預計體育仲裁法院將於7月18號宣佈裁決。不過即使禁令不會撤銷，莎拉波娃都似乎安排好了她網球之外的生活。